Marshall Wace, LLP Cv Rx, Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Cv Rx, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 350,080 shares of CVRX stock, worth $2.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
350,080
Previous 103,532
238.14%
Holding current value
$2.63 Million
Previous $1.27 Million
62.56%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CVRX
# of Institutions
93Shares Held
14.9MCall Options Held
42.2KPut Options Held
32.4K-
Johnson & Johnson New Brunswick, NJ4.1MShares$30.8 Million8.12% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$15.2 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$8.09 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$6.58 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT789KShares$5.93 Million0.62% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $155M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...